Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3205298 | Journal of the American Academy of Dermatology | 2013 | 9 Pages |
Abstract
Rosacea is a common skin disorder with multiple symptoms. The emergence of research that furthers understanding of pathophysiological mechanisms has created new targets for disease treatment. Specifically, there is a need for new treatments that address the various erythematic symptoms associated with rosacea. Systemic and topical therapies have both yielded positive results in treating rosacea with various medications. Subantimicrobial-dose doxycycline is one such promising treatment. Development of novel products in the near future should help achieve more satisfactory outcomes for patients.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Alison Layton, Diane Thiboutot,